Edwards Lifesciences (EW): Officer sold ~$34K
Daniel J. Lippis, Officer at Edwards Lifesciences, sold ~$34K of Edwards Lifesciences shares.
- ~$34K
- Approx. value · 500 sh @ $68.76
- 23K
- Holds after · shares reported
- Traded
- Jan 16, 2025
- Filed
- Jan 16, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 6, 2024Insider · 2 peopleInsiders: 2 sales (~$171K)
- Dec 9, 2024FDAFDA device clearance: HemoSphere Alta Advanced Monitoring Platform (ALTAALL1/ALTCR1/ALTASR1); HemoSphere Alta- monitor pressure cable (HEMAPSC200);Acumen AFM cable- HemoSphere Alta…
- Dec 9, 2024Insider · 2 peopleInsiders: 2 sales (~$1.2M)
- Dec 16, 2024InsiderOfficer sold ~$185K of EW shares in the open market
- Jan 16, 2025 · this disclosureInsiderOfficer sold ~$34K of EW shares in the open market
What came next
- Jan 16, 2025InsiderOfficer sold ~$344K of EW shares in the open market
- Feb 13, 2025Insider · 4 peopleInsiders: 5 sales (~$1.8M)
- Feb 14, 2025InsiderDirector sold ~$439K of EW shares in the open market
- Feb 28, 2025Insider · 1 personInsiders: 2 sales (~$796K)
- Mar 3, 2025Congress · 1 personMembers of Congress: 2 purchases
- Mar 10, 2025Insider · 2 peopleInsiders: 2 sales (~$456K)
- Mar 13, 2025InsiderOfficer sold ~$646K of EW shares in the open market
- Mar 21, 2025FDAFDA device clearance: FloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors
- Mar 26, 2025InsiderCFO sold ~$797K of EW shares in the open market
- Mar 27, 2025FDAFDA device clearance: Edwards eSheath Optima introducer set
- Apr 7, 2025CongressDisclosed purchase of EW — reported range $15,001 - $50,000
- Apr 8, 2025InsiderOfficer sold ~$21K of EW shares in the open market
- Apr 8, 2025CongressDisclosed purchase of EW — reported range $1,001 - $15,000
- Apr 14, 2025InsiderOfficer sold ~$663K of EW shares in the open market
- Apr 21, 2025CongressDisclosed sale of EW — reported range $1,001 - $15,000
- May 5, 2025InsiderCEO sold ~$448K of EW shares in the open market
- May 7, 2025InsiderOfficer sold ~$20K of EW shares in the open market
- May 9, 2025Insider · 2 peopleInsiders: 2 sales (~$862K)
- May 14, 2025FDARecall: Brand Name: Optisite Arterial Cannula Product Name: Optisite Arterial Cannula Model/Catalog Number: OPTI16 Software Version: N/A Product Description: Cardiac c…
- May 14, 2025FDARecall: Brand Name: FEM-FLEX II Product Name: Femoral Arterial Cannula Model/Catalog Number: FEMII016AS Software Version: N/A Product Description: The Edwards FEMFLEXI…
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Edwards Lifesciences
For Edwards Lifesciences, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EW page.
Other recent filings by Daniel J. Lippis, CVP, JAPAC
- SEC Form 4 at Edwards Lifesciences (EW)Nov 10, 2026
- SEC Form 4 at Edwards Lifesciences (EW)Oct 8, 2026
- SEC Form 4 at Edwards Lifesciences (EW)Sep 11, 2026
- SEC Form 4 at Edwards Lifesciences (EW)Aug 11, 2026
- SEC Form 4 at Edwards Lifesciences (EW)Jul 10, 2026
The full history of Daniel J. Lippis, CVP, JAPAC is on the profile page.
How this filing works
Explore the data
Common questions
Which Edwards Lifesciences (EW) insider traded, and how much?
Daniel J. Lippis, Officer at Edwards Lifesciences, sold ~$34K of Edwards Lifesciences shares. 500 shares at $68.76.
When did it happen, and when was it made public?
Traded: Jan 16, 2025. Filed: Jan 16, 2025.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Edwards Lifesciences recently?
For Edwards Lifesciences, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the EW page.
Does this mean EW stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Edwards Lifesciences
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 10, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 144Nov 9, 2026
- SEC Form 144Nov 9, 2026
- SEC Form 4Nov 9, 2026
Everything OQRO holds on this company is on its EW page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
